Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2023-04-19 00:00:00 ET · period of report 2023-04-18 · accession 0001209191-23-024820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-19 | 2023-04-18 | FATE | Chu Yu-Waye | Chief Medical Off | S - Sale | $6.57 | -2,532 | 140.7K | -2% | -$16.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-18 | S | D | 215 | $6.52 | 142,993 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $6.46 to $6.53 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2-3. |
| 2 | Common | Common Stock | 2023-04-18 | S | D | 2,317 | $6.58 | 140,676 | D | — | — | (F3) Represents the weighted average sale price of the shares sold from $6.56 to $6.60 per share. |